{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01671",
      "entity_text" : "NF-kappaB p52 34",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:NFkappaB",
      "entity_text" : "NF-kappaB",
      "features" : [ {
        "modification_type" : "ubiquitination",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Additionally, RANKL can act via the noncanonical route, which is driven by ubiquitination and processing of the cytoplasmic inhibitor NF-kappaB p100 to form NF-kappaB p52 34.",
  "reading_complete" : "2020-08-09T07:45:02Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T07:42:03Z",
  "trigger" : "driven",
  "evidence" : [ "driven by ubiquitination and processing of the cytoplasmic inhibitor NF-kappaB p100 to form NF-kappaB p52 34" ],
  "pmc_id" : "6857990",
  "score" : 0
}